SE9501719D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
SE9501719D0
SE9501719D0 SE9501719A SE9501719A SE9501719D0 SE 9501719 D0 SE9501719 D0 SE 9501719D0 SE 9501719 A SE9501719 A SE 9501719A SE 9501719 A SE9501719 A SE 9501719A SE 9501719 D0 SE9501719 D0 SE 9501719D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
composition
curative
arginine
vivo
Prior art date
Application number
SE9501719A
Other languages
English (en)
Swedish (sv)
Inventor
Diya Adawi
Bengt Jeppson
Goeran Molin
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Priority to SE9501719A priority Critical patent/SE9501719D0/xx
Publication of SE9501719D0 publication Critical patent/SE9501719D0/xx
Priority to KR1019970707930A priority patent/KR19990008403A/ko
Priority to PCT/SE1996/000603 priority patent/WO1996035440A1/en
Priority to BR9608284A priority patent/BR9608284A/pt
Priority to ES96914505T priority patent/ES2112818T3/es
Priority to PL96323320A priority patent/PL184603B1/pl
Priority to CA002220498A priority patent/CA2220498A1/en
Priority to EP96914505A priority patent/EP0825869B1/de
Priority to CNB961953993A priority patent/CN1152678C/zh
Priority to AT96914505T priority patent/ATE221783T1/de
Priority to AU57846/96A priority patent/AU704886B2/en
Priority to JP53399796A priority patent/JP4058560B2/ja
Priority to DE0825869T priority patent/DE825869T1/de
Priority to EE9700269A priority patent/EE03597B1/xx
Priority to DE69622855T priority patent/DE69622855T2/de
Priority to NO19975136A priority patent/NO317668B1/no
Priority to GR980300028T priority patent/GR980300028T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9501719A 1995-05-09 1995-05-09 Pharmaceutical composition SE9501719D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition
DE69622855T DE69622855T2 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
CA002220498A CA2220498A1 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine
CNB961953993A CN1152678C (zh) 1995-05-09 1996-05-08 一种包含植物乳杆菌和精氨酸的药物组合物
BR9608284A BR9608284A (pt) 1995-05-09 1996-05-08 Composição farmacêutica compreendendo lactobacillus plantarum e arginina
ES96914505T ES2112818T3 (es) 1995-05-09 1996-05-08 Composicion farmaceutica que comprende lactobacillus plantarum y arginina.
PL96323320A PL184603B1 (pl) 1995-05-09 1996-05-08 Środek farmaceutyczny do leczenia i lub profilaktyki uszkodzenia i niewydolności wątroby
KR1019970707930A KR19990008403A (ko) 1995-05-09 1996-05-08 락토바실러스 플란타룸 및 아르기닌을 포함하는 제약 조성물
EP96914505A EP0825869B1 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
PCT/SE1996/000603 WO1996035440A1 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine
AT96914505T ATE221783T1 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
AU57846/96A AU704886B2 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine
JP53399796A JP4058560B2 (ja) 1995-05-09 1996-05-08 ラクトバチルス プランタラムおよびアルギニンを含む薬学的組成物
DE0825869T DE825869T1 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
EE9700269A EE03597B1 (et) 1995-05-09 1996-05-08 Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini
NO19975136A NO317668B1 (no) 1995-05-09 1997-11-07 Farmasoytisk blanding omfattende Lactobacillus plantarum og arginin, samt anvendelse derav
GR980300028T GR980300028T1 (en) 1995-05-09 1998-04-30 Pharmaceutical composition comprising lactobacillus plantarum and arginine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
SE9501719D0 true SE9501719D0 (sv) 1995-05-09

Family

ID=20398250

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition

Country Status (16)

Country Link
EP (1) EP0825869B1 (de)
JP (1) JP4058560B2 (de)
KR (1) KR19990008403A (de)
CN (1) CN1152678C (de)
AT (1) ATE221783T1 (de)
AU (1) AU704886B2 (de)
BR (1) BR9608284A (de)
CA (1) CA2220498A1 (de)
DE (2) DE825869T1 (de)
EE (1) EE03597B1 (de)
ES (1) ES2112818T3 (de)
GR (1) GR980300028T1 (de)
NO (1) NO317668B1 (de)
PL (1) PL184603B1 (de)
SE (1) SE9501719D0 (de)
WO (1) WO1996035440A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
IL151596A0 (en) 2000-03-24 2003-04-10 Nestle Sa Use of lactic acid bacterium for the treatment of peritonitis
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
EP1736164A4 (de) 2004-03-31 2009-06-24 Calpis Co Ltd Mittel zur prävention oder suppression von hepatopathie und funktionales nahrungsmittel zur prävention oder suppression von hepatopathie
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
DK3067057T3 (da) * 2005-09-28 2023-02-13 Nordic Rebalance As Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
KR101075557B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
WO2010064434A1 (ja) * 2008-12-03 2010-06-10 国立大学法人広島大学 肝機能障害予防剤
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101255050B1 (ko) * 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
CA3060243A1 (en) 2017-04-17 2018-10-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Also Published As

Publication number Publication date
PL323320A1 (en) 1998-03-16
DE825869T1 (de) 1998-07-16
NO975136D0 (no) 1997-11-07
EE9700269A (et) 1998-04-15
DE69622855T2 (de) 2003-04-10
WO1996035440A1 (en) 1996-11-14
EP0825869B1 (de) 2002-08-07
JP4058560B2 (ja) 2008-03-12
CN1190346A (zh) 1998-08-12
ATE221783T1 (de) 2002-08-15
DE69622855D1 (de) 2002-09-12
NO317668B1 (no) 2004-11-29
CN1152678C (zh) 2004-06-09
AU704886B2 (en) 1999-05-06
BR9608284A (pt) 1999-06-08
AU5784696A (en) 1996-11-29
EP0825869A1 (de) 1998-03-04
CA2220498A1 (en) 1996-11-14
EE03597B1 (et) 2002-02-15
JPH11504936A (ja) 1999-05-11
PL184603B1 (pl) 2002-11-29
ES2112818T3 (es) 2003-02-16
NO975136L (no) 1997-11-07
KR19990008403A (ko) 1999-01-25
ES2112818T1 (es) 1998-04-16
GR980300028T1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
SE9501719D0 (sv) Pharmaceutical composition
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HUP0203185A2 (hu) Vérnyomáscsökkentő di- és tripeptideket termelő Lactobacillus helveticus
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
HUT75555A (en) Lactobacillus strains of human origin, their compositions and uses thereof
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
EP1143985A3 (de) Verwendung von lactobacillus salivarius
MY120501A (en) Micro-encapsulated lactobacilli for medical applications
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
BR0111506A (pt) Complexos de droga macromoleculares e composições contendo os mesmos
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
JPS6483025A (en) Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
Samuel Paediatrics Forum. Acute diarrhoea
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
UA31364A (uk) Спосіб лікування дисбактеріозу кишечнику у хворих на гострий пієлонефрит
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi
AU1756299A (en) Use of putamen ovi